1. Offit, Kenneth 美国 Memorial Sloan Kettering Cancer Center 2016美国医学院院士 Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analys..
2. 王振常 中国 首都医科大学 2023中国工程院院士 Predictive value of lesion morphology in rectal cancer based on MRI before surgery
3. 郎景和 中国 中国医学科学院 中国工程院院士 Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade..
4. Danny Reinberg 美国 New York University 2013美国医学院院士;2015美国科学院院士 SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex
5. 马丁 中国 华中科技大学 中国工程院院士 Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy i..
6. 郎景和 中国 中国医学科学院 中国工程院院士 Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcin..
7. Bulun, Serdar E. 美国 Northwestern University Feinberg School of Medicine 2015美国医学院院士 Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical applicati..
8. 金力 中国 复旦大学上海医学院 中国科学院院士 The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration ..
9. Scott W. Lowe 美国 Memorial Sloan Kettering Cancer Center 2017美国科学院院士;2019美国医学院院士 Molecular Characterization of Acquired Resistance to KRAS G12C-EGFR Inhibition in Colorectal Cancer
10. Kornelia Polyak 美国 Harvard University 2022美国医学院院士;2022美国科学院院士 Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Anal..
11. Colditz, Graham A. 美国 Washington University School of Medicine 2006美国医学院院士 Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Anal..
12. Guillermina,Lozano 美国 University of Texas MD Anderson Cancer Center 2017美国科学院院士；2014美国医学院院士 Is loss of p53 a driver of ductal carcinoma in situ progression?
13. Bulun, Serdar E. 美国 Northwestern University Feinberg School of Medicine 2015美国医学院院士 Uterine Leiomyosarcoma Associated With Leiomyoma With Bizarre Nuclei: Histology and Genomic Analysis..
14. 金力 中国 复旦大学上海医学院 中国科学院院士 Association of Esophageal Squamous Cell Carcinoma With the Interaction Between Poor Oral Health and ..
15. Ernst,Lengyel 美国 University of Chicago 2019美国医学院院士 Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment
16. Timothy A,Chan 美国 Memorial Sloan-Kettering Cancer Center 2023美国医学院院士 Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hurthle cell carcino..
17. Pike, Malcolm C. 美国 Memorial Sloan Kettering Cancer Center 1994美国医学院院士 MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian ..
18. Odunsi, Kunle 美国 The University of Chicago 2018美国医学院院士 MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian ..
19. Karlan, Beth Y. 美国 David Geffen School of Medicine at UCLA 2015美国医学院院士 MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian ..
20. 马丁 中国 华中科技大学 中国工程院院士 Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homolog..